Investigating how sex differences affect the inhibition of blood vessel growth by certain antibodies
Sexual dimorphism in antigen-independent angiogenesis inhibition of IgG1 antibodies
This study is looking at how men and women react differently to a treatment that stops blood vessels from growing, which could help with conditions like age-related macular degeneration and heart disease, and it aims to find out why these differences exist so that future treatments can be better suited for each gender.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10912485 on NIH RePORTER |
What this research studies
This research explores how male and female bodies respond differently to the inhibition of blood vessel growth, particularly in conditions like age-related macular degeneration and heart disease. It focuses on a specific type of antibody, IgG1, which has been found to inhibit blood vessel formation through a mechanism that does not rely on its ability to bind to antigens. By studying these differences, the research aims to uncover the underlying molecular mechanisms that contribute to varying responses in vascular conditions between sexes, potentially leading to more tailored treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to abnormal blood vessel growth, such as age-related macular degeneration, particularly those who are 21 years and older.
Not a fit: Patients with conditions unrelated to angiogenesis or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for vascular diseases that account for sex differences, enhancing patient outcomes.
How similar studies have performed: Previous studies have shown that understanding sex differences in biological responses can lead to significant advancements in treatment approaches, suggesting this research could build on established findings.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Argyle, Dionne Alexis — University of Virginia
- Study coordinator: Argyle, Dionne Alexis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.